48.84
price down icon0.91%   -0.45
after-market 시간 외 거래: 48.84
loading

Supernus Pharmaceuticals Inc (SUPN) 재무 분석

손익 계산서
분기별
*모든 숫자는 백만 단위입니다.
기간 종료일 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
기간 3개월 3개월 3개월 3개월 3개월
Revenues
10.13%
211.57
192.10 165.45 149.82 174.16
Cost Of Revenue
21.31%
23.01
18.96 16.83 15.76 26.10
Gross Profit
8.91%
188.56
173.14 148.63 134.06 148.06
Operating Expenses
17.51%
192.50
233.37 136.49 144.32 126.66
Benefits Costs and Expenses
14.63%
213.49
250.06 148.78 155.66 147.78
Costs And Expenses
14.59%
215.51
252.33 153.31 160.08 152.75
Depreciation and Amortization
0.00%
0.50
0.50 0.50 0.60 0.60
Operating Income/Loss
93.46%
-3.937
-60.23 12.14 -10.26 21.41
Nonoperating Income/Loss
11.16%
2.023
2.277 4.528 4.425 4.977
Income/Loss From Continuing Operations Before Tax
96.70%
-1.914
-57.95 16.67 -5.831 26.38
Income Tax Expense/Benefit, Deferred
818.45%
19.00
-2.645 -7.162 -3.99 -0.072
Income Tax Expense/Benefit
117.07%
2.191
-12.84 -5.83 5.996 11.05
Income/Loss From Continuing Operations After Tax
90.90%
-4.105
-45.12 22.50 -11.83 15.33
Net Income/Loss
90.90%
-4.105
-45.12 22.50 -11.83 15.33
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
99.44%
0.3172
56.55 56.02 55.86 0.1229
Diluted Average Shares
99.44%
0.3172
56.55 56.64 55.86 0.1674
Basic Earnings Per Share
91.25%
-0.07
-0.80 0.40 -0.21 0.28
Diluted Earnings Per Share
91.25%
-0.07
-0.80 0.40 -0.21 0.27
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
drug_manufacturers_specialty_generic RDY
$14.14
price up icon 2.02%
$25.12
price up icon 1.17%
$129.70
price down icon 0.77%
drug_manufacturers_specialty_generic RGC
$27.01
price up icon 2.39%
$13.50
price down icon 1.75%
$527.00
price down icon 0.63%
자본화:     |  볼륨(24시간):